Products

What will AGI do for Bitolterol?

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C28H31NO5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9KY0QXD6LI, chemically known as 4-(2-(tert-butylamino)-1-hydroxyethyl-1,2-phenylen di-4-toluat but generally known as bitolterol, which bears US NIH Compound Identifier 35330. Bitolterol most often comes in base and mesylate forms. European Medicines Agency schedules Bitolterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05860MIG. The term BITOLTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules bitolterol in its Anatomical Therapeutic Chemical (ATC) Classification. BITOLTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bitolterol under HS 29225000 and SITC 51467. As of Q4 2014, BITOLTEROL remains the US FDA Preferred Term for this commodity. Bitolterol bears US NLM identifiers UMLS ID C0053817 and NCI Concept Code C65267. SMILES: OC(CNC(C)(C)C)C1CC(OC(=O)C2CCC(CC2)C)C(OC(=O)C2CCC(CC2)C)CC1.